TY  - JOUR
AU  - Steg, Philippe Gabriel
AU  - Bhatt, Deepak L
AU  - James, Stefan K
AU  - Darlington, Oliver
AU  - Hoskin, Louise
AU  - Simon, Tabassome
AU  - Fox, Kim M
AU  - Leiter, Lawrence A
AU  - Mehta, Shamir R
AU  - Harrington, Robert A
AU  - Himmelmann, Anders
AU  - Ridderstråle, Wilhelm
AU  - Andersson, Marielle
AU  - Bueno, Hector
AU  - De Luca, Leonardo
AU  - Tank, Amarjeet
AU  - Mellström, Carl
AU  - McEwan, Phil
PY  - 2022
DO  - 10.1093/ehjcvp/pvac032
UR  - http://hdl.handle.net/20.500.12105/15782
AB  - To conduct a health economic evaluation of ticagrelor in patients with type 2 diabetes and coronary artery disease (CAD) from a multinational payer perspective. Cost-effectiveness and cost-utility of ticagrelor were evaluated in the overall effect of...
LA  - eng
PB  - Oxford University Press
KW  - Diabetes Mellitus, Type 2
KW  - Ticagrelor
KW  - Humans
KW  - Aspirin
KW  - Coronary Artery Disease
KW  - Cost-Benefit Analysis
KW  - Percutaneous Coronary Intervention
TI  - Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
TY  - journal article
ER  -